Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility Trial

Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility Trial

ObjectiveThe aim of the Cardiovascular Health in Anxiety and Mood Problems Study (CHAMPS) is to pilot the Unified Protocol (UP) for the transdiagnostic treatment of depression and anxiety disorders in patients recently hospitalized for cardiovascular diseases (CVDs) and evaluate the feasibility.Meth...

Full description

Bibliographic Details
Main Authors:	Phillip J. Tully, Deborah A. Turnbull, John D. Horowitz, John F. Beltrame, Bernhard T. Baune, Shannon Sauer-Zavala, Harald Baumeister, Christopher G. Bean, Ronette B. Pinto, Suzie Cosh, Gary A. Wittert
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Psychiatry
Subjects:	depression major depression (MDD) anxiety anxiety disorders cardiovascular disease coronary heart disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2022.741039/full

Similar Items

Identifying the Internalizing Disorder Clusters Among Recently Hospitalized Cardiovascular Disease Patients: A Receiver Operating Characteristics Study
by: Megan Grech, et al.
Published: (2019-12-01)

Executive Function and Spatial Cognition Mediate Psychosocial Dysfunction in Major Depressive Disorder
by: Matthew J. Knight, et al.
Published: (2018-10-01)

Executive Subdomains Are Differentially Associated With Psychosocial Outcomes in Major Depressive Disorder
by: Matthew J. Knight, et al.
Published: (2018-07-01)

Differences in Perceptions of Major Depressive Disorder Symptoms and Treatment Priorities Between Patients and Health Care Providers Across the Acute, Post-Acute, and Remission Phases of Depression
by: Bernhard T. Baune, et al.
Published: (2019-05-01)

Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ?
by: Michael Cronquist Christensen, et al.
Published: (2020-04-01)

Longitudinal early epigenomic signatures inform molecular paths of therapy response and remission in depressed patients
by: Evelien Van Assche, et al.
Published: (2023-08-01)

Analysis of BoDV-1 status, EEG resting-state alpha activity and pro-inflammatory cytokines in adults with and without major depressive disorder
by: Anna J. Torner, et al.
Published: (2024-11-01)

Pharmacogenomics of MDD as a Developing Field: Challenges and Opportunities
by: B. Baune
Published: (2022-06-01)

Microglia: An Interface between the Loss of Neuroplasticity and Depression
by: Gaurav Singhal, et al.
Published: (2017-09-01)

Suicide risk in patients with a current depressive episode during the COVID-19 pandemic
by: Mikhail Zinchuk, et al.
Published: (2024-04-01)

Missed Diagnosis of Major Depressive Disorder with Catatonia Features
by: Harry Jhawer, et al.
Published: (2019-02-01)

Transdiagnostic Effects of Schizophrenia Polygenic Scores on Treatment Outcomes in Major Psychiatric Disorders
by: Serretti A, et al.
Published: (2025-03-01)

An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response
by: Bernhard T. Baune, et al.
Published: (2024-01-01)

The Direct and Indirect Relationship Between Social Cognition and Psychosocial Dysfunction in Major Depressive Disorder
by: Matthew J. Knight, et al.
Published: (2019-05-01)

The efficacy of integrated transdiagnostic treatment in reducing worry, anxiety, depressive and emotional regulation in patients with generalized anxiety disorder
by: Shalir Kolah-Zari, et al.
Published: (2023-11-01)

Projections of anxiety disorder prevalence during and beyond the COVID-19 pandemic in Germany using the illness–death model
by: Chisato Ito, et al.
Published: (2024-09-01)

Comparison of the effect of group transdiagnostic therapy and group cognitive therapy on anxiety and depressive symptoms.
by: Abolfazl Mohammadi, et al.
Published: (2013-01-01)

A review of the role of social cognition in major depressive disorder
by: Michael James Weightman, et al.
Published: (2014-12-01)

Psychosocial Dysfunction in Major Depressive Disorder—Rationale, Design, and Characteristics of the Cognitive and Emotional Recovery Training Program for Depression (CERT-D)
by: Matthew James Knight, et al.
Published: (2017-12-01)

Clinical, functional and biological correlates of cognitive dimensions in major depressive disorder - rationale, design, and characteristics of the Cognitive Function and Mood Study (CoFaM-Study)
by: Bernhard Theodor Baune, et al.
Published: (2016-08-01)

Evaluation of a transdiagnostic treatment for adolescents with comorbid anxiety and depression
by: Carolyn A. Schniering, et al.
Published: (2020-12-01)

Impact of Adjunctive VNS on Drug Load, Depression Severity, and Number of Neuromodulatory Maintenance Treatments
by: Erhan Kavakbasi, et al.
Published: (2024-02-01)

Evaluation of additional resources used in therapist-assisted transdiagnostic internet-delivered cognitive behaviour therapy
by: H.D. Hadjistavropoulos, et al.
Published: (2024-09-01)

Cognitive and Functional Assessment of Psychosis Stratification Study (CoFAPSS): Rationale, Design, and Characteristics
by: Scott R. Clark, et al.
Published: (2018-12-01)

Impact of a transdiagnostic prevention protocol for targeting adolescent anxiety and depression
by: Sharon Allan, et al.
Published: (2020-12-01)

Generalized anxiety disorder and major depressive disorder among healthcare professionals in Mbarara city, southwestern Uganda: the relationship with professional quality of life and resilience
by: Joan Abaatyo, et al.
Published: (2025-03-01)

Role of anxiety and depressive disorders in the genesis of psychosomatic disorders
by: Aleksandr Anatolyevich Shatenshtein
Published: (2013-11-01)

Manifestation of anxiety and depression and their association with cardiovascular diseases in the Lithuanian population
by: Neringa Burokienė, et al.
Published: (2014-12-01)

Concentrated transdiagnostic and cross-disciplinary group treatment for patients with depression and with anxiety: a pilot study
by: Gerd Kvale, et al.
Published: (2022-09-01)

Systematic review of the neurobiological relevance of chemokines to psychiatric disorders
by: Michael eStuart, et al.
Published: (2015-09-01)

Unified Protocol for Transdiagnostic Prevention of Depression and Anxiety in Iranian Adolescents: Protocol Development and Initial Outcome Data
by: Mehdi Soleimani, et al.
Published: (2019-05-01)

Inflammasomes in neuroinflammation and changes in brain function: a focused review
by: Gaurav eSinghal, et al.
Published: (2014-10-01)

The contribution of transdiagnostic vulnerability factors in patients with chronic insomnia
by: Mojtaba Habibi Asgarabad, et al.
Published: (2023-04-01)

Efficacy of transdiagnostic cognitive-behavioral therapy for assertiveness: A randomized controlled trial
by: Tobias Hagberg, et al.
Published: (2023-04-01)

Cross-cultural adaptation and validation of the Sinhala version of the Hospital Anxiety and Depression Scale (HADS) for patients diagnosed with ischemic heart disease (IHD) in Sri Lanka
by: C. K. W. Gamage, et al.
Published: (2023-05-01)

Prevalence of Anxiety and Depression in Stable Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital
by: C Selvi, et al.
Published: (2019-01-01)

Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study
by: Lou Peian, et al.
Published: (2012-09-01)

Association of Psilocybin Use in Adolescents with Major Depressive Episode
by: K. Shah, et al.
Published: (2022-06-01)

Treating comorbid insomnia in patients enrolled in therapist-assisted transdiagnostic internet-delivered cognitive behaviour therapy for anxiety and depression: A randomized controlled trial
by: M. Edmonds, et al.
Published: (2024-03-01)

Phosphodiesterase 4 Inhibition in Neuropsychiatric Disorders Associated with Alzheimer’s Disease
by: Jiming Chen, et al.
Published: (2025-01-01)